Please enable JavaScript to continue using this application.

Compare $ANNX vs $IMMX | Chartloom

Compare

$ANNX vs $IMMX

Annexon Inc · Immix Biopharma Inc

ANNX

Annexon Inc

IMMX

Immix Biopharma Inc

Compare $ANNX vs $IMMX

Comparing Annexon Inc and Immix Biopharma Inc

ANNXAnnexon Inc

IMMXImmix Biopharma Inc

ANNXAnnexon Inc

Market cap

$659M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

21.66x

Rev growth (TTM)

—

YTD performance

-14.3%

52W performance

27.6%

FCF yield

-29.3%

IMMXImmix Biopharma Inc

Market cap

$660M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

74.2%

52W performance

272.4%

FCF yield

-5.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANNX

IMMX

Detailed metrics comparison

ANNX

Annexon Inc

IMMX

Immix Biopharma Inc

Market Cap

ANNX$659M

IMMX$660M

Enterprise Value

ANNX$459M

IMMX$435M

Price

ANNX$4.02

IMMX$9.46

P/E Ratio

ANNXN/A

IMMXN/A

P/S Ratio

ANNX0.00x

IMMX0.00x

EV/Sales

ANNX0.00x

IMMX0.00x

EV/EBITDA

ANNX0.00x

IMMX0.00x

P/B Ratio

ANNX4.27x

IMMX3.03x

P/FCF Ratio

ANNXN/A

IMMXN/A

EV/FCF

ANNX-2.38x

IMMX-11.12x

PEG Ratio

ANNXN/A

IMMXN/A

Forward P/E (NTM)

ANNXN/A

IMMXN/A

Forward P/S (NTM)

ANNX21.66x

IMMXN/A

Revenue (TTM)

ANNX$0

IMMX$0

Revenue Growth (YoY)

ANNXN/A

IMMXN/A

Forward Rev Growth

ANNX370.6%

IMMX452.1%

Gross Margin (TTM)

ANNX0.0%

IMMX0.0%

Operating Margin (TTM)

ANNX0.0%

IMMX0.0%

EBITDA Margin (TTM)

ANNX0.0%

IMMX0.0%

Net Margin (TTM)

ANNX0.0%

IMMX0.0%

FCF Margin (TTM)

ANNXN/A

IMMXN/A

Net Income (TTM)

ANNX$-203M

IMMX$-40M

FCF (TTM)

ANNX$-193M

IMMX$-39M

EPS (TTM)

ANNX-$1.01

IMMX-$0.63

ROE (TTM)

ANNX-10615.0%

IMMX-3844.0%

ROA (TTM)

ANNX-7982.0%

IMMX-3472.0%

ROIC (TTM)

ANNX-10615.0%

IMMX-3844.0%

Cash

ANNX$199M

IMMX$225M

Debt

ANNX$0

IMMX$0

Net Cash/Debt

ANNX$199M

IMMX$225M

Current Ratio (TTM)

ANNX5.53x

IMMX25.13x

Quick Ratio (TTM)

ANNX5.44x

IMMX24.98x

Debt/Equity (TTM)

ANNX0.00x

IMMX0.00x

Debt/Assets (TTM)

ANNX0.0%

IMMX0.0%

Interest Coverage (TTM)

ANNXN/A

IMMXN/A

Net Debt/EBITDA (TTM)

ANNX0.00x

IMMX0.00x

Beta

ANNX1.40

IMMX0.22

52W Performance

ANNX27.6%

IMMX272.4%

YTD Performance

ANNX-14.3%

IMMX74.2%

% from 52W High

ANNX-44.0%

IMMX-37.4%

% from 52W Low

ANNX58.3%

IMMX309.5%

Asset Turnover (TTM)

ANNX0.00x

IMMX0.00x

FCF Yield (TTM)

ANNX-29.3%

IMMX-5.9%

Earnings Yield (TTM)

ANNX-30.8%

IMMX-6.0%

Dividend Yield (TTM)

ANNXN/A

IMMXN/A

Rule of 40

ANNX0.0

IMMX0.0

EV/GP/RG

ANNXN/A

IMMXN/A

Ticker research

View ANNX research View IMMX research

Metric	ANNX Annexon Inc	IMMX Immix Biopharma Inc
Market & Valuation
Market Cap	$659M	$660M
Enterprise Value	$459M	$435M
Price	$4.02	$9.46
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.27x	3.03x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.38x	-11.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	21.66x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	370.6%	452.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-203M	$-40M
FCF (TTM)	$-193M	$-39M
EPS (TTM)	-$1.01	-$0.63
ROE (TTM)	-10615.0%	-3844.0%
ROA (TTM)	-7982.0%	-3472.0%
ROIC (TTM)	-10615.0%	-3844.0%
Financial Health
Cash	$199M	$225M
Debt	$0	$0
Net Cash/Debt	$199M	$225M
Current Ratio (TTM)	5.53x	25.13x
Quick Ratio (TTM)	5.44x	24.98x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.40	0.22
52W Performance	27.6%	272.4%
YTD Performance	-14.3%	74.2%
% from 52W High	-44.0%	-37.4%
% from 52W Low	58.3%	309.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-29.3%	-5.9%
Earnings Yield (TTM)	-30.8%	-6.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ANNX research	View IMMX research

Valuation

P/S Ratio

ANNX

0.00x

IMMX

0.00x

EV/FCF

IMMX

-11.12x

ANNX

-2.38x

Growth & revenue

Forward Revenue Growth

IMMX

452.1%

ANNX

370.6%

Profitability & performance

Gross Margin

ANNX

0.0%

IMMX

0.0%

ROE

IMMX

-3844.0%

ANNX

-10615.0%

FCF Yield %

IMMX

-5.9%

ANNX

-29.3%

52-Week Performance

IMMX

272.4%

ANNX

27.6%

Detailed metrics comparison

ANNX

Annexon Inc

IMMX

Immix Biopharma Inc

Market Cap

ANNX$659M

IMMX$660M

Enterprise Value

ANNX$459M

IMMX$435M

Price

ANNX$4.02

IMMX$9.46

P/E Ratio

ANNXN/A

IMMXN/A

P/S Ratio

ANNX0.00x

IMMX0.00x

EV/Sales

ANNX0.00x

IMMX0.00x

EV/EBITDA

ANNX0.00x

IMMX0.00x

P/B Ratio

ANNX4.27x

IMMX3.03x

P/FCF Ratio

ANNXN/A

IMMXN/A

EV/FCF

ANNX-2.38x

IMMX-11.12x

PEG Ratio

ANNXN/A

IMMXN/A

Forward P/E (NTM)

ANNXN/A

IMMXN/A

Forward P/S (NTM)

ANNX21.66x

IMMXN/A

Revenue (TTM)

ANNX$0

IMMX$0

Revenue Growth (YoY)

ANNXN/A

IMMXN/A

Forward Rev Growth

ANNX370.6%

IMMX452.1%

Gross Margin (TTM)

ANNX0.0%

IMMX0.0%

Operating Margin (TTM)

ANNX0.0%

IMMX0.0%

EBITDA Margin (TTM)

ANNX0.0%

IMMX0.0%

Net Margin (TTM)

ANNX0.0%

IMMX0.0%

FCF Margin (TTM)

ANNXN/A

IMMXN/A

Net Income (TTM)

ANNX$-203M

IMMX$-40M

FCF (TTM)

ANNX$-193M

IMMX$-39M

EPS (TTM)

ANNX-$1.01

IMMX-$0.63

ROE (TTM)

ANNX-10615.0%

IMMX-3844.0%

ROA (TTM)

ANNX-7982.0%

IMMX-3472.0%

ROIC (TTM)

ANNX-10615.0%

IMMX-3844.0%

Cash

ANNX$199M

IMMX$225M

Debt

ANNX$0

IMMX$0

Net Cash/Debt

ANNX$199M

IMMX$225M

Current Ratio (TTM)

ANNX5.53x

IMMX25.13x

Quick Ratio (TTM)

ANNX5.44x

IMMX24.98x

Debt/Equity (TTM)

ANNX0.00x

IMMX0.00x

Debt/Assets (TTM)

ANNX0.0%

IMMX0.0%

Interest Coverage (TTM)

ANNXN/A

IMMXN/A

Net Debt/EBITDA (TTM)

ANNX0.00x

IMMX0.00x

Beta

ANNX1.40

IMMX0.22

52W Performance

ANNX27.6%

IMMX272.4%

YTD Performance

ANNX-14.3%

IMMX74.2%

% from 52W High

ANNX-44.0%

IMMX-37.4%

% from 52W Low

ANNX58.3%

IMMX309.5%

Asset Turnover (TTM)

ANNX0.00x

IMMX0.00x

FCF Yield (TTM)

ANNX-29.3%

IMMX-5.9%

Earnings Yield (TTM)

ANNX-30.8%

IMMX-6.0%

Dividend Yield (TTM)

ANNXN/A

IMMXN/A

Rule of 40

ANNX0.0

IMMX0.0

EV/GP/RG

ANNXN/A

IMMXN/A

Ticker research

View ANNX research View IMMX research

Metric	ANNX Annexon Inc	IMMX Immix Biopharma Inc
Market & Valuation
Market Cap	$659M	$660M
Enterprise Value	$459M	$435M
Price	$4.02	$9.46
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.27x	3.03x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.38x	-11.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	21.66x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	370.6%	452.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-203M	$-40M
FCF (TTM)	$-193M	$-39M
EPS (TTM)	-$1.01	-$0.63
ROE (TTM)	-10615.0%	-3844.0%
ROA (TTM)	-7982.0%	-3472.0%
ROIC (TTM)	-10615.0%	-3844.0%
Financial Health
Cash	$199M	$225M
Debt	$0	$0
Net Cash/Debt	$199M	$225M
Current Ratio (TTM)	5.53x	25.13x
Quick Ratio (TTM)	5.44x	24.98x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.40	0.22
52W Performance	27.6%	272.4%
YTD Performance	-14.3%	74.2%
% from 52W High	-44.0%	-37.4%
% from 52W Low	58.3%	309.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-29.3%	-5.9%
Earnings Yield (TTM)	-30.8%	-6.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ANNX research	View IMMX research